Evidence mapPaperPMID 41883804Full record

ReviewFrontiers in microbiology2026

Host-gut microbiota interactions in health and disease: mechanisms and intervention strategies.

Yu Han, Zian Wang, Jiahao Xie, Guangdi Yang, Monong Su, Siqi Wang, Mengxin Yang, Huiyang Yu, Minghua Li, Liang Wang and 2 more

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Programming the tumor microenvironment through microbiome-driven mechanisms.Frontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu Han *Department of Dermatology, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Zian Wang *Department of Gastrointestinal Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Jiahao Xie *Department of Gastrointestinal Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Guangdi YangDepartment of Dermatology, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Monong SuLaboratory Animal Centre, Dalian Medical University, Dalian, China.
Siqi WangLaboratory Animal Centre, Dalian Medical University, Dalian, China.
Mengxin YangDepartment of Dermatology, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Huiyang YuLaboratory Animal Centre, Dalian Medical University, Dalian, China.
Minghua LiKunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.
Liang WangLaboratory Animal Centre, Dalian Medical University, Dalian, China.
Yunying ZhangDepartment of Dermatology, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Binbin HouDepartment of Dermatology, Second Affiliated Hospital of Dalian Medical University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mammalian gut microbiota is a complex and dynamic "microbial organ" that interacts with its host. The gut microbiota contains a vast gene pool and metabolic capacity, producing key metabolites such as short-chain fatty acids (SCFAs), bile acids, vitamins, and other compounds. These metabolites regulate core physiological functions like energy metabolism, immune homeostasis, and neural behavior via the gut-brain axis (GBA), immune signaling networks, and other pathways. This review explores the bidirectional regulatory role of the gut microbiota. The gut microbiota influences the host's metabolism and immune functions through its metabolites and structural components, while the host's physiological state, internal environment, and lifestyle can alter the microbiota's composition and function, creating a complex feedback network. Furthermore, the main mechanisms of dysbiosis in diseases are also explored. Dysregulation of the gut microbiota can damage the intestinal mucosal barrier, induce chronic inflammation, disrupt metabolic and immune signaling, and contribute to diseases such as type 2 diabetes, non-alcoholic fatty liver disease, inflammatory bowel disease, rheumatoid arthritis, and neurodegenerative disorders. Microbiota-based interventions, such as probiotics, prebiotics, and fecal microbiota transplantation (FMT), can be promising in disease management, but their clinical applications face challenges, including individual genetic backgrounds, lifestyles, and environmental factors, as well as difficulties in achieving long-term colonization of specific strains. Future research needs to uncover precise causal mechanisms in host-microbe interactions, as well as develop individualized microbiota intervention strategies to provide new theoretical bases and practical tools for the prevention, diagnosis, and treatment of major diseases.

Indexed as

bidirectional regulationdysbiosisgut microbiotahostintervention strategiesmammals

Identifiers

PMID41883804
PMCPMC13008890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.